Evidence map›Paper›PMID 30787097›Full record

ArticlePediatrics2019

The Potential Benefits of Research May Justify Certain Research Risks.

David Wendler, Robert M Nelson, John D Lantos

Abstract read
In one paragraph

Article in Pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Prenatally-diagnosed renal failure: an ethical framework for decision-making.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

David WendlerDepartment of Bioethics, National Institutes of Health, Bethesda, Maryland.
Robert M NelsonChild Health Innovation Leadership Department, Johnson & Johnson, Raritan, New Jersey; and.
John D LantosDepartment of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri jlantos@cmh.edu.

Funding

Research and clinical care without informed consentZIACL010537 · CLC · CLINICAL CENTER · PI WENDLER, DAVID S · 2014 to 2025
$0k
Intramural NIH HHS ZIA CL010537
6 · The paper itself

Abstract

US regulations allow institutional review boards to approve pediatric clinical trials only when the risks are minimal or (in some cases) a minor increase over minimal, or when the risks are justified by a potential for direct benefit to the participants. But how should an institutional review board determine if the risks of pediatric clinical trials are justified by a potential for participant benefit? In this Ethics Rounds article, we consider which potential benefits can justify which research risks with a focus on randomized clinical trials.

Indexed as

Administration, IntravenousBiliary AtresiaBiomedical ResearchChildEthics Committees, ResearchGlucocorticoidsHumansMethylprednisoloneProspective StudiesRandomized Controlled Trials as TopicRisk AssessmentGlucocorticoidsMethylprednisolone

Identifiers

PMID30787097
PMCPMC10081016

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.